Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Naama

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Immunology|November 1, 1983
Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritisJ K Naama, W S Mitchell, K Whaley
Clinical and Experimental Immunology|April 1, 1985
Prevention of immune precipitation by purified components of the alternative pathwayJ K Naama, E Holme, E Hamilton, et al.
Immunology|July 1, 1984
IgM-RF prevents complement-mediated inhibition of immune precipitationW S Mitchell, J K Naama, J Veitch, et al.
Clinical and Experimental Immunology|February 1, 1986
Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditisM A Kerr, E Wilton, J K Naama, et al.
Clinical and Experimental Immunology|February 1, 1983
Complement-mediated inhibition of immune precipitation in patients with immune complex diseasesJ K Naama, W S Mitchell, A Zoma, et al.
Scandinavian Journal of Rheumatology|January 1, 1984
Inhibition of immune precipitation in rheumatic disease. A clinical and laboratory studyJ K Naama, W S Mitchell, D Lewis, et al.
Clinical and Experimental Immunology|November 1, 1984
Prevention of immune precipitation by purified classical pathway complement componentsJ K Naama, A O Hamilton, A C Yeung-Laiwah, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1985
Complement, antigen-antibody complexes and immune complex diseaseJ K Naama, I P Niven, A Zoma, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Immunology|November 1, 1983
Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritisJ K Naama, W S Mitchell, K Whaley
Clinical and Experimental Immunology|April 1, 1985
Prevention of immune precipitation by purified components of the alternative pathwayJ K Naama, E Holme, E Hamilton, et al.
Immunology|July 1, 1984
IgM-RF prevents complement-mediated inhibition of immune precipitationW S Mitchell, J K Naama, J Veitch, et al.
Clinical and Experimental Immunology|February 1, 1986
Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditisM A Kerr, E Wilton, J K Naama, et al.
Clinical and Experimental Immunology|February 1, 1983
Complement-mediated inhibition of immune precipitation in patients with immune complex diseasesJ K Naama, W S Mitchell, A Zoma, et al.
Scandinavian Journal of Rheumatology|January 1, 1984
Inhibition of immune precipitation in rheumatic disease. A clinical and laboratory studyJ K Naama, W S Mitchell, D Lewis, et al.
Clinical and Experimental Immunology|November 1, 1984
Prevention of immune precipitation by purified classical pathway complement componentsJ K Naama, A O Hamilton, A C Yeung-Laiwah, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1985
Complement, antigen-antibody complexes and immune complex diseaseJ K Naama, I P Niven, A Zoma, et al.
Pageof 1